Acorda Therapeutics Inc (NASDAQ:ACOR)

31.61
Delayed Data
As of May 26
 -0.40 / -1.25%
Today’s Change
28.26
Today|||52-Week Range
45.45
-22.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line30.6M155.0M16.4M17.7M
 
 
 
 
 
Depreciation4.6M4.7M7.0M8.5M
 
 
 
 
 
Total Other Cash Flow39.8M25.8M27.4M46.4M
 
 
 
 
 
Funds From Operations75.1M52.4M60.4M79.2M
 
 
 
 
 
Funds From/For Other Operating Expenses8.7M213.0K21.2M4.2M
 
 
 
 
 
Net Cash Flow - Operating Activities66.3M52.2M39.2M74.9M
 
 
 
 
 
 
InvestingIncrease In Investments-266.7M-322.5M-221.4M-580.4M
 
 
 
 
 
Decrease In Investments227.5M264.8M191.0M770.5M
 
 
 
 
 
Capital Expenditures-2.2M-10.4M-4.0M-5.1M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-7.5M-476.2M
 
 
 
Net Cash Flow Investing-45.0M-71.3M-45.1M-293.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00337.5M
 
 
Long Term Debt Reduction-2.0M-1.3M-909.0K-562.0K
 
 
 
 
 
Net Proceeds Stock Sale4.0M4.3M12.8M16.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.0091.0K0.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.0M3.1M12.0M352.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.001.0K
 
 
 
Net Change In Cash23.3M-16.0M6.1M134.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account